{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:00:33Z","timestamp":1761058833837,"version":"3.33.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1136\/ard.52.2.110","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"110-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antinuclear antibodies in routine analysis: the relevance of putative clinical associations."],"prefix":"10.1016","volume":"52","author":[{"given":"A.J","family":"Swaak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Huysen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology","volume":"44","author":"M, Tan E.","year":"1989","unstructured":"Tan E M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-126.","journal-title":"Adv Immunol"},{"issue":"2","key":"ref_2","first-page":"105","article-title":"Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus","volume":"9","author":"G, Swaak A.J.; V, Huysen; C, Nossent J.; T, Smeenk R.J.","year":"1990","unstructured":"Swaak A J G, Huysen V, Nossent J C, Smeenk R J T. Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheum Dis 1990; 9 (suppl 2): 105-10.","journal-title":"Clin Rheum Dis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archderm.1988.01670010025016","article-title":"Anti-Ro (SSA) and anti-LA (SSB) antibodies in lupus erythematosus and in Sjogren's syndrome","volume":"124","author":"A, Lee L.","year":"1988","unstructured":"Lee L A. Anti-Ro (SSA) and anti-LA (SSB) antibodies in lupus erythematosus and in Sjogren's syndrome. Arch Dermatol 1988; 124: 61-2.","journal-title":"Arch Dermatol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archderm.1988.01670010027017","article-title":"The relationship between anti-Ro (SSA) antibody-positive Siogren's syndrome and anti-Ro (SSA) antibody-positive lupus erythematosus","volume":"124","author":"T, Provost T.; N, Talal; B, Houley J.; M, Reichlin; E, Alexander","year":"1988","unstructured":"Provost T T, Talal N, Houley J B, Reichlin M, Alexander E. The relationship between anti-Ro (SSA) antibody-positive Siogren's syndrome and anti-Ro (SSA) antibody-positive lupus erythematosus. Arch Dermatol 1988; 124: 63-71.","journal-title":"Arch Dermatol"},{"key":"ref_5","first-page":"512","volume-title":"Fetal complete heart block. Br HeartJI","volume":"60","author":"L, Machado M.V.","year":"1988","unstructured":"Machado M V L, Tynan M J, Curry P V L, Allan L D. Fetal complete heart block. Br HeartJI 1988; 60: 512-5."},{"key":"ref_6","first-page":"391","article-title":"Clinical significance of anti-Ro (SSA) antibody in rheumatoid arthritis","volume":"15","author":"Boire, G.; Menard, H.","year":"1988","unstructured":"Boire G, Menard H. Clinical significance of anti-Ro (SSA) antibody in rheumatoid arthritis. J Rheumatol 1988; 15: 391-4.","journal-title":"J Rheumatol"},{"key":"ref_7","first-page":"1271","article-title":"revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"M, Tan E.; S, Cohen A.; F, Fries J.","year":"1982","unstructured":"Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.","journal-title":"The"},{"key":"ref_8","first-page":"175","article-title":"1958 revision of diagnostic criteria for rheumatoid arthritis","volume":"9","author":"W, Ropes M.; A, Bennet G.; S, Cobb; R, Jacox; A, Jessar R.","year":"1958","unstructured":"Ropes M W, Bennet G A, Cobb S, Jacox R, Jessar R A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175-6.","journal-title":"Bull Rheum Dis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic lupus sclerosis (scleroderma)","volume":"23","author":"T, Masi A.; P, Rodnan G.; A, Medsges T.","year":"1980","unstructured":"Masi A T, Rodnan G P, Medsges T A, et al. Preliminary criteria for the classification of systemic lupus sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.","journal-title":"Arthritis Rheum"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.1780190309","article-title":"Identification of antibodies to nuclear acid-antigens by counter immunoelectrophoresis","volume":"19","author":"Kurata, H.; M, Tan E.","year":"1976","unstructured":"Kurata H, Tan E M. Identification of antibodies to nuclear acid-antigens by counter immunoelectrophoresis. Arthritis Rheum 1976; 19: 574-80.","journal-title":"Arthritis Rheum"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/art.1780250814","article-title":"Reference sera for ANA. I. Antibodies to native DNA, Sm, nuclear RNP and SS-B","volume":"25","author":"M, Tan E.; J, Frizler M.; S, McDougal J.","year":"1982","unstructured":"Tan E M, Frizler M J, McDougal J S, et al. Reference sera for ANA. I. Antibodies to native DNA, Sm, nuclear RNP and SS-B. Arthritis Rheum 1982; 25: 1003-9.","journal-title":"Arthritis Rheum"},{"key":"ref_12","first-page":"27","article-title":"Anti La (SSB) identifies a distinctive subgroup of systemic lupus erythematosus","volume":"27","author":"J, Maddison P.; A, Isenberg D.; J, Goulding N.; J, Leddy; P, Skinner R.","year":"1988","unstructured":"Maddison P J, Isenberg D A, Goulding N J, Leddy J, Skinner R P. Anti La (SSB) identifies a distinctive subgroup of systemic lupus erythematosus. BrJ7 Rheumatol 1988; 27: 27-31."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0896-8411(88)90023-6","article-title":"Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counter immunoelectrophoresis and immunoblotting","volume":"1","author":"A, Westgeest A.; van der Brink H G; de Jong J; G, Swaak A.J.; T, Smeenk R.J.","year":"1988","unstructured":"Westgeest A A, van der Brink H G, de Jong J, Swaak A J G, Smeenk R J T. Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counter immunoelectrophoresis and immunoblotting. J Autoimmun 1988; 1: 159-70.","journal-title":"J Autoimmun"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.1780310406","article-title":"Two RO (SS-A) auto-antibody responses in systemic lupus erythematosus","volume":"31","author":"G, Hamilton R.; B, Harley J.; B, Bias W.","year":"1988","unstructured":"Hamilton R G, Harley J B, Bias W B, et al. Two RO (SS-A) auto-antibody responses in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 496-505.","journal-title":"Arthritis Rheum"},{"key":"ref_15","first-page":"769","article-title":"Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease","volume":"82","author":"D, Parker M.","year":"1973","unstructured":"Parker M D. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease. J Lab Clin Med 1973; 82: 769-75.","journal-title":"J Lab Clin Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0002-9343(83)90612-5","article-title":"Clinical significance of anti-Sm antibodies in systemic lupus erythematosus","volume":"74","author":"Beaufils, M.; Kouki, F.; Mignon, F.; Camus, J.; Morel-Maroger, L.; Richet, G.","year":"1983","unstructured":"Beaufils M, Kouki F, Mignon F, Camus J, Morel-Maroger L, Richet G. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. AmJf Med 1983; 74: 201-5.","journal-title":"AmJf Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/art.1780221203","article-title":"Identification of a clinical subset of systemic lupus erythematosus by antibodies to","volume":"22","author":"M, Winn D.; F, Wolfe J.; A, Lindberg D.; H, Fristoe F.; L, Kringsland; C, Sharp G.","year":"1979","unstructured":"Winn D M, Wolfe J F, Lindberg D A, Fristoe F H, Kringsland L, Sharp G C. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the Sm antigen. Arthritis Rheum 1979; 22: 1334-7.","journal-title":"the Sm antigen. Arthritis Rheum"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.1780230718","article-title":"Specificity of Sm antibody","volume":"23","author":"Reinitz, E.; Grayzel, A.; Barland, P.","year":"1980","unstructured":"Reinitz E, Grayzel A, Barland P. Specificity of Sm antibody [letter]. Arthritis Rheum 1980; 23: 869.","journal-title":"Arthritis Rheum"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/art.1780241003","article-title":"Antibodies to Sm in patients with systemic lupus erythematosus","volume":"24","author":"A, Barada F.; S, Andrews B.; S, Davis J.; P, Tayler R.","year":"1981","unstructured":"Barada F A, Andrews B S, Davis J S, Tayler R P. Antibodies to Sm in patients with systemic lupus erythematosus. Arthritis Rheum 1981; 24: 1236-44.","journal-title":"Arthritis Rheum"},{"key":"ref_20","first-page":"132","article-title":"Substantial purification of the Sm antigen and association ofhigh titer antibody to Sm with a clinical subset of systemic lupus erythematosus","volume":"20","author":"Powers, R.; Akizuk, M.; J, Boehm-Truitt M.; R, Holman H.","year":"1977","unstructured":"Powers R, Akizuk M, Boehm-Truitt M J, Holman H R. Substantial purification of the Sm antigen and association ofhigh titer antibody to Sm with a clinical subset of systemic lupus erythematosus [abstract]. Arthritis Rheum 1977; 20: 132.","journal-title":"Arthritis Rheum"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.1780240109","article-title":"Survivorship in systemic lupus erythematosus","volume":"24","author":"C, Hochberg M.; A, Dorsch C.; J, Feinglass E.; B, Stevens M.","year":"1981","unstructured":"Hochberg M C, Dorsch C A, Feinglass E J, Stevens M B. Survivorship in systemic lupus erythematosus. Arthritis Rheum 1981; 24: 54-9.","journal-title":"Arthritis Rheum"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/03009748409100383","article-title":"Laitirien 0. Anti ribonucleoprotein antibodies in inflammatory rheumatic diseases","volume":"13","author":"Piirairien, H.; Gripenberg, M.","year":"1984","unstructured":"Piirairien H, Gripenberg M, Laitirien 0. Anti ribonucleoprotein antibodies in inflammatory rheumatic diseases. ScandJ Rheumatol 1984; 13: 177-80.","journal-title":"ScandJ Rheumatol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/03009748409102662","article-title":"Incidence and clinical significance of anti ENA antibodies in systemic lupus erythematosus","volume":"13","author":"Clotet, B.; Guardia, J.; Pigran, C.","year":"1984","unstructured":"Clotet B, Guardia J, Pigran C, et al. Incidence and clinical significance of anti ENA antibodies in systemic lupus erythematosus. ScandJ Rheumatol 1984; 13: 15-20.","journal-title":"ScandJ Rheumatol"},{"key":"ref_24","first-page":"407","article-title":"Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein","volume":"5","author":"Maddison, P.; Mogavero, H.; Reichlin, M.","year":"1978","unstructured":"Maddison P, Mogavero H, Reichlin M. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein. J7 Rheumatol 1978; 5: 407-11."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724033910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724033910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.52.2.110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T06:10:32Z","timestamp":1737439832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724033910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["S0003496724033910"],"URL":"https:\/\/doi.org\/10.1136\/ard.52.2.110","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1993,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinuclear antibodies in routine analysis: the relevance of putative clinical associations.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.52.2.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1993 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}